Can a 4-session talk therapy prevent PTSD after a burn injury?

NCT ID NCT07656545

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a short, 4-session therapy for burn survivors and their caregivers to prevent posttraumatic stress disorder (PTSD). The therapy, called Promotion of Emotional Disclosure for Burns (PoED-B), helps patients and their loved ones communicate better about the traumatic event by reducing negative reactions and encouraging supportive conversations. The trial includes a small group of hospitalized burn patients and their caregivers, with some receiving the therapy and others receiving standard education. The goal is to see if this approach is acceptable, feasible, and reduces PTSD symptoms.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Promotion of Emotional Disclosure for Burns (PoED-B) - a behavioral therapy
What this could lead to
If effective, this therapy could offer a simple, short-term way to prevent PTSD in burn survivors and their loved ones by improving how they talk about the trauma.
What could go wrong
This is a small early-stage trial with only 44 participants, so results may not apply to everyone. The therapy is brief and may not work for all types of trauma or relationships.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute stress disorder burn injury Stress Disorders, Traumatic Stress Disorders, Traumatic, Acute post-traumatic stress disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Southern California, Keck School of Medicine & Los Angeles General Medical Center

    Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.